Bizarre Patents
Process For Propelling Foodstuffs or the Like into a Crowd
A method of launching foodstuffs into a crowd for promotional and entertainment purposes.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8178510 | Preparation of thioarabinofuranosyl compounds and use thereof Patients suffering from cancer are treated by being administered a compound represented by the following formula: wherein each R individually is H or an aliphatic or aromatic acyl group; ... | 05/15/2012 |
| 8158605 | Azacytidine analogues and uses thereof The present invention is directed toward compounds of Formula (I) as follows: wherein, R is H, R5C(O); R1 is | 04/17/2012 |
| 8158606 | β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies It has been discovered that β-L-2′-deoxynucleosides are active against drug-resistant hepatitis B virus with mutations. A method for treating lamivudine resistant HBV (M552V) in a host is provided that includes administering a β-L-2′-deoxynucleoside or its pha... | 04/17/2012 |
| 8143234 | Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function The present invention provides methods of improving a cognitive function or a neurological function, treating or ameliorating a decline in a cognitive function or a neurological function, increasing cytidine levels, or treating a neurological disorder in a subject, ... | 03/27/2012 |
| 8129358 | Substituted pyrazole and triazole compounds as KSP inhibitors Disclosed are new substituted pyrazole and triazole compounds of Formula (I) and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the derivatives together with pharmaceutically acceptable carriers, and uses thereof: ... | 03/06/2012 |
| 8124593 | Methods of treatment using sapacitabine A first aspect of the invention relates to a method of treating leukaemia or myelodysplastic syndromes (MDS), said method comprising administering a therapeutically effective amount of sapacitabine, or a metabolite thereof, to a subject in accordance with a dosing r... | 02/28/2012 |
| 8114854 | Crystalline forms of gemcitabine amide prodrug, compositions and use thereof The present invention relates to novel crystal forms of an amide prodrug of gemcitabine, compositions thereof and methods for using. ... | 02/14/2012 |
| 8071567 | 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions c... | 12/06/2011 |
| 8067392 | Compositions and methods for treatment of mitochondrial diseases Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidien nucleotide precursors in amounts sufficient to treat symptoms result... | 11/29/2011 |
| 8067391 | ODCase inhibitors for the treatment of malaria The present invention includes methods of treating or preventing malaria by administering an anti-malarial effective amount of 6-substituted uridine derivatives to a subject need thereof. The invention also includes new 6-substituted uridine derivatives for use as t... | 11/29/2011 |
| 8058261 | 3′-ethynylcytidine derivative To provide a compound which exhibits excellent anti-tumor activity and excellent oral absorption and which is a useful anti-tumor drug. The invention provides a 3′-ethynylcytidine derivative represented by formula (1): | 11/15/2011 |
| 8058260 | 2′-C-methyl-ribofuranosyl cytidine prodrugs, pharmaceutical compositions and uses thereof The present disclosure provides 2′-C-methyl-ribofuranosyl cytidine prodrugs, methods of making 2′-C-methyl-ribofuranosyl cytidine prodrugs, pharmaceutical compositions of 2′-C-methyl-ribofuranosyl cytidine prodrugs, and methods of using 2′-C-methyl-ribofuran... | 11/15/2011 |
| 8044033 | Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer The present invention provides, in certain embodiments, methods for the treatment of colorectal cancer comprising administering a COX-2 inhibitor and fluorocytidine derivative to a human patient. In certain embodiments, a radiation therapy is also administered to th... | 10/25/2011 |
| 8044034 | Nanoparticle derivatives of gemcitabine The use of squalenic acid or a derivative thereof in formulating at least one polar active principle with a molecular weight of 100 Da or more, in the form of nanoparticles, and pharmaceutical compositions thereof. ... | 10/25/2011 |
| 8022047 | Combination anticancer agents A cancer therapeutic agent comprising a combination of compound A described below, or a pharmaceutically acceptable salt thereof, and compound B described below, or a pharmaceutically acceptable salt thereof: Compound A represented by the formula of cla... | 09/20/2011 |
| 7951788 | Method of treating cancer and other conditions or disease states using L-cytosine nucleoside analogs The present invention relates to the use of the compound according to formula (I) Where S is (A) or (B); X is H or F; R1 is H, an acyl group, a C1-C20 alkyl or ether group, a phosphate, diphosphate, triphosphate or a phosphodiester g... | 05/31/2011 |
| 7951787 | Phosphoramidate compounds and methods of use Phosphoramidate derivatives of nucleotides and their use in the treatment of cancer are described. The base moieties of, for example, each of deoxyuridine, cytarabine, gemcitabine and citidine may be substituted at the 5-position. The phosphoramidate moiety has atta... | 05/31/2011 |
| 7947661 | Compounds for the treatment of marihuana dependence, withdrawal, and usage The invention provides methods for treating or suppressing marihuana usage, withdrawal, or dependence involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, uridine-containing compound, creatine-conta... | 05/24/2011 |
| 7932235 | Triazolyl tropane derivatives This invention relates to novel triazolyl tropane derivatives, their acceptable acid addition salts, solvates, hydrates and polymorphs thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in metho... | 04/26/2011 |
| 7928086 | β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies It has been discovered that β-L-2′-deoxynucleosides are active against drug-resistant hepatitis B virus with mutations. A method for treating lamivudine resistant HBV (M552V) in a host is provided that includes administering a β-L-2′-deoxynucleoside or its pha... | 04/19/2011 |
| 7915233 | Compositions and methods for treatment of mitochondrial diseases Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidien nucleotide precursors in amounts sufficient to treat symptoms result... | 03/29/2011 |
| 7893037 | Pharmaceutical composition and process The present invention relates to a method of forming granules of (2R,3S,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2-azido-3,4-bis-iso-butyryloxy-tetrahydro-furan-2-ylmethyl isobutyrate; hydrochloride salt (I), comprising mixing I, with a granulating amount of a gra... | 02/22/2011 |
| 7879815 | Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection The present invention provides nucleoside aryl phosphoramidates of structural formula (I) which are precursors to inhibitors of RNA-dependent RNA viral polymerase. These compounds are precursors to inhibitors of RNA-dependent RNA viral replication and are useful for... | 02/01/2011 |
| 7863254 | Compounds for the treatment of psychiatric or substance abuse disorders The invention provides methods for treating or preventing psychiatric and substance abuse disorders, involving administration of a therapeutically-effective amount of a cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-cont... | 01/04/2011 |
| 7863255 | Methods of administering antitumor agent comprising deoxycytidine derivative Antitumor treatment regimens comprising: administering, to a patient diagnosed with cancer, an antitumor agent comprising 4-amino-1-(2-cyano-2-deoxy-β-D-arabinofuranosyl)-2(1H)-pyrimidinone, or a salt thereof, by way of continuous intravenous infusion, in an amount... | 01/04/2011 |
| 7858594 | Crystalline and amorphous forms of beta-L-2′-deoxythymidine Physical forms of beta-L-2′-deoxythymidine are disclosed that can be characterized by physical appearance, purity levels, Infra-Red and Raman spectroscopy, X-ray powder diffraction patterns, thermal properties, and methods of manufacture. These forms of beta-L-2â€... | 12/28/2010 |
| 7842675 | Deuterium-enriched capecitabine The present application describes deuterium-enriched capecitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. ... | 11/30/2010 |
| 7838508 | 4′-thio-L-xyloy furanosyl nucleosides, precursors thereof, preparation and use thereof Compounds represented by the formula 1: A is selected from the group consisting of wherein each R ... | 11/23/2010 |
| 7829548 | Compounds useful in the treatment of HIV There is provided inter alia use of 2′,3′-dideoxy-3′-hydroxymethylcytidine or a prodrug or salt thereof in the manufacture of a medicament for the treatment of HIV infection wherein the reverse transcriptase of the HIV bears at least one mutation that allows a... | 11/09/2010 |
| 7825103 | Pyrimidine nucleoside compound or its salt Provided is a pyrimidine nucleoside compound represented by the following formula (1): or a pharmaceutically acceptable salt thereof, wherein one of X and Y represents a cyano group, and the other represents a hydrogen atom... | 11/02/2010 |
| 7816339 | Treatments for Flaviviridae virus infection The present invention provides methods for treating infections, in a host, by viruses belonging to the Flaviviridae family, such as HCV, comprising administering an Ara-C homologue to the host. ... | 10/19/2010 |
| 7807655 | Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system The invention relates to the use of a pyrimidine nucleotide for treating affections of the peripheral nervous system, particularly polyneuropathies, neuritides, and myopathies, and the use thereof for stimulating the regeneration of nerves. ... | 10/05/2010 |
| 7807654 | Compositions and methods for treatment of mitochondrial diseases Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms result... | 10/05/2010 |
| 7803785 | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof The present invention provides gemcitabine prodrugs, methods of making gemcitabine prodrugs, pharmaceutical compositions of gemcitabine prodrugs and methods of using gemcitabine prodrugs and pharmaceutical compositions of using gemcitabine prodrugs to treat or preve... | 09/28/2010 |
| 7795237 | Pharmaceutical composition and process The present invention relates to a pharmaceutical composition comprising a solid suspension prepared by hot melt extrusion of isobutyric acid (2R,3S,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2-azido-3,4-bis-iso-butyryloxy-tetrahydro-furan-2-ylmethyl ester; hydrochl... | 09/14/2010 |
| 7776838 | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides The subject invention discloses compounds, compositions and methods for treatment and prevention of toxicity due to chemotherapeutic agents and antiviral agents. Disclosed are acylated derivatives of non-methylated pyrimidine nucleosides. These compounds are capable... | 08/17/2010 |
| 7772208 | 2′,3′-dideoxynucleoside analogues for the treatment or prevention of infections A method for the treatment or prevention of Flaviviridae infections, in particular, hepatitis C virus infection, in a host, and in particular, a human, is provided that includes administering an effective amount of a β-L- or β-D-2′,3′-dideoxynucleoside or a ph... | 08/10/2010 |
| 7772207 | Combination of a CDK inhibitor and CS-682 or a metabolite thereof A first aspect of the invention relates to a combination comprising a CDK inhibitor and 1-(2-C-cyano-2-dioxy-β-D-arabino-pentofuranosyl)-N4-palmitoyl cytosine, or a metabolite thereof. A second aspect of the invention relates to a pharmaceutical product comprising ... | 08/10/2010 |
| 7754699 | Antiviral nucleosides Compounds having the formula I wherein R1 is as herein defined are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for inhibiting hepatitis replication, and processes for making the compounds of formula I | 07/13/2010 |
| 7704972 | Gemcitabine derivatives nanoparticles The invention concerns a 2′,2′-difluoro-2′-deoxycytidine derivative of general formula (I), wherein: R1, R2 and R3, identical or different, represent independently of one another, a hydrogen atom or an at least C18 h... | 04/27/2010 |
